Results showed that most thalassemia patients that received blood with twenty-day interval between transfusions were positive for CMV IgM antibody nevertheless, no significant difference was found in our study (p >0.05) regarding the relationship between transfusion intervals and the prevalence antibodies in patients. Here, CD40LG is linked to thalassemia.